The Department of Justice has sued both OhioHealth and NewYork-Presbyterian Hospital this year, alleging that they use contracting tactics that limit competition and keep healthcare prices high. The ...

President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.

Antibody drug conjugates bring a targeted approach to the treatment of many types of cancer, but there’s still room for improving this class of therapies. This week, two startups revealed how they aim ...

In today’s fast-moving, hyper-connected world, legal and compliance teams shield organizations from a constant stream of internal and external threats to sensitive data. Effectively countering these ...

Jefferson Health in Philadelphia is suing Aetna over a new Medicare Advantage payment policy that hospitals say unfairly ...

Generic medicines face no tariffs, though the Trump administration reserves the right to revisit that in the future. Some ...

Luminai CEO Kesava Kirupa Dinakaran said the startup’s platform is built using 3 layers. The first is data transformation. The AI engine first converts messy healthcare documents like faxes and PDFs ...

Chapter, a Medicare navigation platform, announced on Thursday that it raised $100 million in Series E funding. The New York-based company’s AI platform compares health plans from every insurance ...

Oral peptide drugs are having a moment. FDA approvals in recent months include the first peptide pills for obesity and plaque psoriasis, each providing an alternative to injectable medications.

Biogen is acquiring Apellis Pharmaceuticals in a $5.6 billion deal that brings two FDA-approved products commercialized in four indications, all of which are expected to contribute to the revenue ...

Many cancer drugs work by blocking proteins associated with tumor progression, but there’s growing industry interest in drugs that eliminate such proteins altogether. Gilead Sciences and Roche have ...